Evidence map›Paper›PMID 32764942›Full record

ArticleInternational journal of nanomedicine2020

Effect of Graphene Oxide and Silver Nanoparticles Hybrid Composite on

Povilas Lozovskis, Virginija Jankauskaitė, Asta Guobienė, Violeta Kareivienė, Astra Vitkauskienė

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Synthesis of Graphene@CPharmaceutical nanotechnology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Evaluation of the wound healing effect of neomycin-silver nano-composite gel in rats.International journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Povilas LozovskisFaculty of Medicine, Lithuanian University of Health Science, Kaunas, Lithuania.
Virginija JankauskaitėDepartment of Production Engineering, Kaunas University of Technology, Kaunas, Lithuania.ORCID 0000-0002-4852-6736
Asta GuobienėInstitute of Materials Science, Kaunas University of Technology, Kaunas, Lithuania.ORCID 0000-0002-1421-0012
Violeta KareivienėFaculty of Medicine, Lithuanian University of Health Science, Kaunas, Lithuania.
Astra VitkauskienėFaculty of Medicine, Lithuanian University of Health Science, Kaunas, Lithuania.
Lithuanian University of Health Sciences · LTKaunas University of Technology · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last decades, nosocomial infections caused by drug-resistant

methodsChemical state, particle size distribution, and morphology of synthesized GO-Ag NH were investigated using spectroscopy and microscopy techniques (UV-Vis, FTIR, XPS, TEM, SEM, AFM). Broad-spectrum antibiotic resistance of

resultsIn this study, the toxicity of the GO-Ag NH to the isolated clinical

conclusionA graphene oxide and silver nanoparticles hybrid composite has been shown to be a promising material to control nosocomial infections caused by bacteria strains resistant to most antibiotics.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGraphiteMetal NanoparticlesPseudomonas aeruginosaSilverAnti-Bacterial Agentsgraphene oxideGraphiteSilverantibacterial activitycarbapenem-resistant bacteriagraphene oxide nanosheetshybrid nanocompositePseudomonas aeruginosasilver nanoparticles

Identifiers

PMID32764942
PMCPMC7381769
OpenAlexW3043548302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.